Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.

@article{Schimmel2009IncreasedLL,
  title={Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.},
  author={Elizabeth K Schimmel and Yusuf Yazici},
  journal={Clinical and experimental rheumatology},
  year={2009},
  volume={27 3},
  pages={446-51}
}
BACKGROUND Cardiovascular disease (CVD) is a major cause of increased mortality in rheumatoid arthritis (RA) patients, and it is recommended to treat risk factors for CVD in RA patients aggressively, including increased lipid levels. However, the effect of biological disease modifying antirheumatic drugs (DMARD) on the lipid profile of RA patients remains under-researched, and what data exist are often contradictory. OBJECTIVES To review available data published to date on lipid profile… CONTINUE READING